Skip to main content
. 2011 Jul 15;124(14):2438–2447. doi: 10.1242/jcs.079954

Fig. 4.

Fig. 4.

Loss of Gal-3 increases the number of neuroblasts in the RMS. (A) Long-term BrdU regimen. (B) The number of BrdU+ label-retaining cells in the SVZ is not significantly different in Gal-3 mutants. (C) Example of labeling for BrdU (red), Dcx (green) and DAPI (blue) in the RMS of a Gal3−/− mouse. (D) The number of BrdU+ cells is increased in the RMS of mutants; **P<0.005. (E,F) Dcx immunohistochemistry in the RMS of a WT and Gal3−/− mouse. Scale bar: 100 μm. (G) The surface area of the RMS, measured by outlining the perimeter of Dcx immunofluorescence, is increased in Gal3-nulls. **P<0.0001. All error bars represent s.e.m.